Cargando…
S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes
Robust induction of cancer-antigen-specific CD8(+) T cells is essential for the success of cancer peptide vaccines, which are composed of a peptide derived from a cancer-specific antigen and an immune-potentiating adjuvant, such as a Toll-like receptor (TLR) agonist. Efficient delivery of a vaccine...
Autores principales: | Nakagawa, Takayuki, Tanino, Tetsuya, Onishi, Motoyasu, Tofukuji, Soichi, Kanazawa, Takayuki, Ishioka, Yukichi, Itoh, Takeshi, Kugimiya, Akira, Katayama, Kazufumi, Yamamoto, Takuya, Nagira, Morio, Ishii, Ken J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735836/ https://www.ncbi.nlm.nih.gov/pubmed/35003132 http://dx.doi.org/10.3389/fimmu.2021.803090 |
Ejemplares similares
-
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
por: Awasthi, Sita, et al.
Publicado: (2023) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency
por: Yoshida, Mari, et al.
Publicado: (2017) -
The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018) -
A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component
por: Yoshioka, Yuya, et al.
Publicado: (2023)